Related Experiment Video
Updated: Mar 16, 2026

10:37
Analysis of HBV-Specific CD4 T-cell Responses and Identification of HLA-DR-Restricted CD4 T-Cell Epitopes Based on a Peptide Matrix
Published on: October 20, 2021
3.5K
Correlation between low tapasin expression and impaired CD8+ T‑cell function in patients with chronic hepatitis B
Yuyan Tang1, Jieling Wang1, Yi Zhang1
1Department of Infectious Disease, Shanghai Jiaotong University Affiliated Sixth People's Hospital, Shanghai 200233, P.R. China.
Molecular Medicine Reports
|August 12, 2016
Summary
Decreased tapasin expression is linked to chronic hepatitis B virus (HBV) infection, impacting T-cell responses and potentially contributing to disease pathogenesis.
Area of Science:
- Immunology
- Virology
- Molecular Biology
Background:
- Chronic hepatitis B virus (HBV) infection impairs T-cell responses.
- Tapasin is crucial for antigen processing and T-cell induction.
- The role of tapasin in chronic HBV (CHB) is not well understood.
Purpose of the Study:
- To investigate the association between tapasin expression and CHB.
- To evaluate the impact of tapasin on CD8+ T-cell responses in CHB patients.
Main Methods:
- Quantified tapasin mRNA in peripheral blood mononuclear cells (PBMCs) from CHB, acute HBV (AHB), and healthy controls using RT-qPCR.
- Assessed CD8+ T-cell responses, including apoptosis and interferon-gamma (IFN-γ) production.
- Analyzed correlations between tapasin expression and CD8+ T-cell immune parameters.
Main Results:
- Tapasin mRNA levels were significantly downregulated in CHB patients compared to AHB patients and healthy controls.
- CHB patients exhibited increased CD8+ T-cell apoptosis and reduced IFN-γ+CD8+ T-cell percentages.
- Tapasin expression positively correlated with IFN-γ production and inversely correlated with CD8+ T-cell apoptosis.
Conclusions:
- Reduced tapasin expression is closely associated with CHB.
- Tapasin may play a significant role in the pathogenesis of CHB by affecting T-cell immunity.
- Restoring tapasin function could be a potential therapeutic strategy for CHB.

